Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 176

Zeus Living settles into $55m series B

Airbnb and Comcast both supplied a share of the funding, which the temporary accommodation provider raised at a $205m post-money valuation.

Dec 11, 2019

SoftBank buys into Style Theory’s $15m series B

Fashion hire service Style Theory collected the cash from existing investor SoftBank Ventures Asia, Paradise Group and Alpha JWC Ventures.

Dec 9, 2019

Group 42 oils HeyGears with $60m

The 3D printing technology provider received $60m from Group 42 in the form of a series B1 investment that marks the corporate's third in a Chinese company this year.

Dec 9, 2019

Anaconda consumes $22m

Existing backer Banco Sabadell Venture Capital contributed to a round that will help the stroke surgery device developer fund clinical studies.

Dec 9, 2019

Hummingbird feeds on $19m

Kooksoondang Brewery took part in a series B round for oncology antibody developer Hummingbird Bioscience as it prepares to move its lead assets into the clinic.

Dec 9, 2019

Infinitum Electric grabs Chevron for series B

Chevron Technology Ventures supplied part of the $12.5m in series B funding secured by electric motor technology developer Infinitum Electric.

Dec 6, 2019

Flow floats to $37m series B

Fung Capital-backed cross-border services business Flow won the backing of American Express Ventures in a round that will fund platform development and hiring.

Dec 6, 2019

ImCheck imports $53m in series B cash

Pfizer Ventures led the immuno-oncology drug developer's latest round, which was spun out of Institut Paoli-Calmettes with the help of Satt Sud-Est and Inserm Transfert.

Dec 5, 2019

Carmakers pull into May Mobility’s $50m series B

Autonomous bus fleet operator May Mobility secured the return of Toyota AI Ventures and BMW i Ventures to bring its overall funding to $84m.

Dec 5, 2019

ImCheck imports $53m in series B cash

Pfizer Ventures led the immuno-oncology drug developer's latest round, which included existing backer Boehringer Ingelheim Venture Fund.

Dec 5, 2019
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here